PUBLIC COMPANY
saveAstellas Pharma US Inc
updated 3mo ago
Astellas Pharma Inc. is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd. .
community read0 votes
🐶 often sniffed alongside
top 5pipeline
6
marketed
6
phase 3
0
catalysts ytd
1
approvals ytd
1
recalls ytd
0
Pipeline(6)
pipeline depth6 products
6Marketed
Marketed
amphotericin B
Aspergillosis
Marketedavacincaptad pegol sodium
Geographic Atrophy
Marketedfezolinetant
Vasomotor Symptoms of Menopause (Hot Flashes)
Marketedgilteritinib fumarate
Refractory Acute Myeloid Leukemia
Marketedisavuconazonium sulfate
Aspergillosis
Marketedmirabegron ER
Neurogenic Bladder Dysfunction
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →🐶 Hiring Signal
News
- 9 midsize drugmakers climb aboard Trump’s MFN trainAstellas Pharma, BridgeBio, BeOne Medicines and six other large biotechs join the 17 Big Pharmas that previously signed on to President Donald Trump’s Most Favored Nation (MFN) drug pricing program…biospace · 29d ago
Data sources
Found something off?
comments(0)
5-min edit window · permanent after that